Skip to main content
Premium Trial:

Request an Annual Quote

Fisher Biosciences and Dyomics to Develop Protein Products

NEW YORK, Jan. 9 (GenomeWeb News) - Fisher Biosciences will develop and manufacture protein and nucleic acid-detection products as part of a collaboration with Dyomics, Fisher said today.


Fisher currently offers protein-research products based primarily on chemiluminescent and colorimetric detection under its Pierce brand. Under the collaboration, the brand will include fluorescently labeled reagents


The parent company of Fisher Biosciences, Fisher Scientific International, recently acquired an equity interest in Dyomics.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.